Role of Functional Imaging in Head and Neck Squamous Cell Carcinoma: Fluorodeoxyglucose Positron Emission Tomography and Beyond

被引：9
|
作者：
Porceddu, Sandro V. [1 ,2 ]
Burmeister, Bryan H. [1 ,2 ]
Hicks, Rodney J. [3 ]
机构：
[1] Princess Alexandra Hosp, Div Canc Serv, Brisbane, Qld 4102, Australia
[2] Univ Queensland, Sch Med, Brisbane, Qld 4102, Australia
[3] Peter MacCallum Canc Ctr, Ctr Mol Imaging, Melbourne, Vic 8006, Australia
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2008年 / 22卷 / 06期
关键词：
PET; Head and neck; Squamous cell carcinoma; Radiotherapy; Chemotherapy;
D O I：
10.1016/j.hoc.2008.08.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Positron emission tomography (PET) has emerged as an integral diagnostic tool in the management of head and neck squamous cell carcinoma (HNSCC). This article reviews the usefulness and ongoing dilemmas of fluorine-18 fluorodeoxyglucose (18-F FDG) PET and FDG PET/CT in HNSCC. In addition, it examines the potential role of novel markers and biologic characterization of disease, which in the future may assist in targeted therapeutic strategies.
引用
收藏
页码：1221 / +
页数：20
相关论文
共 50 条
  • [1] Fluorodeoxyglucose-Positron-Emission Tomography Imaging of Head and Neck Squamous Cell Cancer
    Subramaniam, R. M.
    Truong, M.
    Peller, P.
    Sakai, O.
    Mercier, G.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2010, 31 (04) : 598 - 604
  • [2] Clinical Role of Positron Emission Tomography/ Computed Tomography Imaging in Head and Neck Squamous Cell Carcinoma
    Abdalla, Abdelrahman Sherif
    Sheybani, Natasha D.
    Khan, Saad A.
    PET CLINICS, 2022, 17 (02) : 213 - 222
  • [3] Role of Pretreatment Fluorodeoxyglucose Positron Emission Tomography Quantitative Parameters in Prognostication of Head-and-Neck Squamous Cell Carcinoma
    Subramaniam, Narayana
    Balasubramanian, Deepak
    Sundaram, P. Shanmuga
    Murthy, Samskruthi
    Thankappan, Krishnakumar
    Iyer, Subramania
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2019, 40 (01) : 21 - 27
  • [4] Current use of 18F-fluorodeoxyglucose positron emission tomography and combined positron emission tomography and computed tomography in squamous cell carcinoma of the head and neck
    Zimmer, LA
    Branstetter, BF
    Nayak, JV
    Johnson, JT
    LARYNGOSCOPE, 2005, 115 (11): : 2029 - 2034
  • [5] Prognostic value of fluorine-18 fluorodeoxyglucose positron-emission tomography imaging in patients with head and neck squamous cell carcinoma
    Querellou, Solene
    Abgral, Ronan
    Le Roux, Pierre-Yves
    Nowak, Emmanuel
    Valette, Gerald
    Potard, Gael
    Le Duc-Pennec, Alexandra
    Cavarec, Marie-Beatrice
    Marianovski, Remi
    Salauen, Pierre-Yves
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2012, 34 (04): : 462 - 468
  • [6] Update on 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers
    Menda, Y
    Graham, MM
    SEMINARS IN NUCLEAR MEDICINE, 2005, 35 (04) : 214 - 219
  • [7] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging of a Patient with Squamous Cell Carcinoma of Prostate
    Gedik, Gonca Kara
    Yavas, Guler
    Akand, Murat
    Celik, Esin
    Sari, Oktay
    CASE REPORTS IN MEDICINE, 2014, 2014
  • [8] Positron Emission Tomography in Head and Neck Squamous Cell Carcinoma of Unknown Primary
    Kinder, Kimberly J.
    Lavertu, Pierre
    Yao, Min
    PET CLINICS, 2012, 7 (04) : 443 - +
  • [9] Effect of 18F-Fluorodeoxyglucose Positron Emission Tomography on the Management of Patients with Head and Neck Squamous Cell Carcinoma
    Goyal, Parul
    Hsu, Jack M.
    Kellman, Robert M.
    JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2008, 37 (05): : 694 - 699
  • [10] Positron Emission Tomography/Computed Tomography in Evaluation of the Clinically NO Neck in Head and Neck Squamous Cell Carcinoma
    Ferris, Robert L.
    Cramer, John D.
    Branstetter, Barton F.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (20) : 1683 - +
12345